S-Alpha Therapeutics, Inc., Digital Therapeutics Start-Up Raises $8.7 Million In Series A Funding
Amount Raised
$8.7 Million
Round Type
Series A
PittsburghBiotechnologyDescription
On July 31st 2021, S-Alpha Therapeutics, Inc., (“S-Alpha” CEO: Seung-Eun Choi), a startup dedicated in R&D for digital therapeutics, announced the completion of its Series A financing.
Quick answer
KaliVir Immunotherapeutics raised $8.7 Million in a Series A round, dated August 9, 2021. KaliVir Immunotherapeutics is based in Pittsburgh, Pennsylvania, United States.
- How much did KaliVir Immunotherapeutics raise?
- KaliVir Immunotherapeutics raised $8.7 Million in a Series A round on August 9, 2021.
- What does KaliVir Immunotherapeutics do?
- KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells.
- Where is KaliVir Immunotherapeutics based and how big is it?
- KaliVir Immunotherapeutics is based in Pittsburgh, Pennsylvania, United States. Fundz records about 29 employees.
- Who are the decision-makers at KaliVir Immunotherapeutics?
- Fundz holds 1 contact at KaliVir Immunotherapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as KaliVir Immunotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Opentrons Labworks raised $209M on September 23, 2021.
- PhenoBiome raised an undisclosed amount (Funding Round) on September 23, 2021.
- Opentrons Labworks raised $200M (Series C) on September 23, 2021.
- Garuda Therapeutics raised $72M (Series A) on September 23, 2021.
- GenEdit raised an undisclosed amount (Series A) on September 23, 2021.
- Nusano raised $48M on September 23, 2021.
Who to call at KaliVir Immunotherapeutics, and when
A new round usually means KaliVir Immunotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day KaliVir Immunotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KaliVir Immunotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KaliVir Immunotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KaliVir Immunotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKaliVir Immunotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.